Larry Todd Edwards, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 14,902 shares at $14.07 ($210K) on 2025-05-19, disclosed to the SEC on 2025-05-20.
Scheduled sale ($210k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.07 | 7,451 | $105K | 50.0% |
| 2 | $14.07 | 7,451 | $105K | 50.0% |
| Total | $14.07 avg | 14,902 | $210K | 100% |
| Filing → |
| ARQT | SELL | 2025-11-10 | $1.5M | — | Filing → |
| ARQT | SELL | 2025-10-06 | $174K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $28K | — | Filing → |